entertainment -WSS

entertainment

author：hotspot 2025-10-01 02:16:10 - browse：5278

Moderna's mResvia vaccine — The FDA has approved Moderna’s RSV vaccine for older adults. Moderna

The Food and Drug Administration on Friday approved Moderna’s vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the company’s second licensed product.

The Moderna RSV vaccine, which will be marketed under the name mResvia, was approved for adults 60 and older. It is made using the same messenger RNA platform as Moderna’s other licensed product, its Covid-19 vaccine Spikevax.

“The FDA approval of our second product, mResvia, builds on the strength and versatility of our mRNA platform,” Moderna CEO Stéphane Bancel said in a statement.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Achieving telehealth equity for people with hearing loss

WSS

Lawsuit challenges CMS nursing home minimum staffing rule

Decentralized clinical trials need collaboration to achieve wider use

2 US Navy sailors arrested for allegedly spying for China

Louisiana bill approved classifying abortion pills as controlled substances

Why some fertility treatments produce more boy babies

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

entertainment

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Apple is now the first public company to be valued at $3 trillion

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

The high cost of giving birth even with insurance

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Anesthesiologist group: stop taking Ozempic before surgery

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

BioMarin wins approval for gene therapy to treat hemophilia A

New research sheds light on how often breast cancer is overdiagnosed

hotspot

What Henrietta Lacks settlement says about racism in medicine

My superpower is killing ticks

The Bio Revolution is changing business and society

OTC birth control: A brief history of over the counter pill design

Biden calls for immediate release of Niger's president amid apparent coup

Stroke rates rising, especially in working

entertainment

hotspot

explore

knowledge